The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict OMNOVA Solutions's revenues will wane -5.8% and EPS will contract 0.0%.
The average estimate for revenue is $283.9 million. On the bottom line, the average EPS estimate is $0.14.
Last quarter, OMNOVA Solutions reported revenue of $288.2 million. GAAP reported sales were 8.5% lower than the prior-year quarter's $315.0 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at $0.16. GAAP EPS of $0.14 for Q3 were much higher than the prior-year quarter's $0.01 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 20.1%, 410 basis points better than the prior-year quarter. Operating margin was 6.7%, 200 basis points better than the prior-year quarter. Net margin was 2.2%, 210 basis points better than the prior-year quarter.
The full year's average estimate for revenue is $1.15 billion. The average EPS estimate is $0.67.
The stock has a two-star rating (out of five) at Motley Fool CAPS, with 145 members out of 171 rating the stock outperform, and 26 members rating it underperform. Among 36 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 33 give OMNOVA Solutions a green thumbs-up, and three give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on OMNOVA Solutions is buy, with an average price target of $10.50.
The rich are different than you and me: They might not notice the moneymaking stories right under our noses. In our new report, "Middle-Class Millionaire-Makers: 3 Stocks Wall Street's Too Rich to Notice," we give you three Peter Lynch-inspired buy-what-you-know stocks for the 99%. Click here for instant access to this free report.
- Add OMNOVA Solutions to My Watchlist.
Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor of Motley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
More from The Motley Fool
Stock Market Today: Monsanto’s Spring Pop and OMNOVA’s Competitive Struggles
Why Monsanto and OMNOVA solutions are on the move today.
Can OMNOVA Profit in DuPont and Dow's Shadow?
The specialty chemical maker is a tiny player in a big industry and needs to maneuver carefully in light of giants DuPont and Dow Chemical.
The $35 Billion "Mad Men" Marriage
Two top ad firms exchange wedding vows.